Wang Bei, Han Zhi-Yu, Yu Jie, Cheng Zhigang, Liu Fangyi, Yu Xiao-Ling, Chen Chaonan, Liu Ju, Liang Ping
a Department of Interventional Ultrasound , Chinese PLA General Hospital , Beijing , PR China.
b Department of Ultrasound , Shandong Provincial Qianfoshan Hospital, Shandong University , Jinan , Shandong , PR China.
Int J Hyperthermia. 2017 Jun;33(4):459-464. doi: 10.1080/02656736.2016.1274058. Epub 2017 Jan 12.
To determine the factors affecting the recurrence of the solitary benign thyroid nodules (BTN) after microwave ablation (MWA).
Between January 2013 and January 2015, a total of 110 patients with at least one solid thyroid nodule (solid component ≥ 80%) were enrolled. MWA was performed under continuous ultrasound (US) guidance. Before and during the follow-up, the thyroid nodule volume, thyroid function and cosmetic complaints were evaluated. Recurrence is defined by the new blood flow in the total ablation area or/and > 50% increase in nodule volume.
Almost all thyroid nodules were significantly decreased in size after MWA. After 12 months, the average volume of thyroid nodules was decreased from 12.6 ± 15.1 to 3.2 ± 5.7 ml. Of the total 110 patients, 16 cases had recurrence 12 months after MWA, and these patients had a larger initial volume than that of the non-recurrence patients (11.6 ± 14.9 vs. 23.9 ± 12.5, p < 0.01). The recurrence group also demonstrated more irregular blood vessels (1.8 8 ± 1.1 vs. 2.8 5 ± 1.3, p < 0.05), and a lower energy (1575.5 ± 674.3 J/ml vs. 1172.3 ± 454.2 J/ml, p < 0.01). In addition, 81.2% (13/16) of the patients in the recurrence group were adjacent to the vital structures, which is significantly higher than that of the non-recurrence group 28.7% (27/94) (p < 0.01).
The US-guided MWA results in a satisfactory long-term outcome of the patients with a benign solitary thyroid nodule. We identified three risk factors for recurrence: initial volume, vascularity and the energy per 1 ml reduction in nodular volume.
确定影响微波消融(MWA)后孤立性良性甲状腺结节(BTN)复发的因素。
2013年1月至2015年1月,共纳入110例至少有一个实性甲状腺结节(实性成分≥80%)的患者。在连续超声(US)引导下进行MWA。在随访前及随访期间,评估甲状腺结节体积、甲状腺功能及美容方面的不适。复发定义为整个消融区域出现新的血流或/和结节体积增大>50%。
几乎所有甲状腺结节在MWA后体积均显著减小。12个月后,甲状腺结节的平均体积从12.6±15.1 ml降至3.2±5.7 ml。110例患者中,16例在MWA后12个月出现复发,这些患者的初始体积大于未复发患者(11.6±14.9 vs. 23.9±12.5,p<0.01)。复发组还显示出更多不规则血管(1.88±1.1 vs. 2.85±1.3,p<0.05),且能量较低(1575.5±674.3 J/ml vs. 1172.3±454.2 J/ml,p<0.01)。此外,复发组中81.2%(13/16)的患者结节邻近重要结构,显著高于未复发组的28.7%(27/94)(p<0.01)。
超声引导下的MWA对良性孤立性甲状腺结节患者可产生满意的长期疗效。我们确定了三个复发危险因素:初始体积、血管情况及每1 ml结节体积缩小所需的能量。